Background Pneumonia is a major cause of morbidity and
P
neumonia is a leading cause of morbidity and mortality in children under five years of age. 1 The 2007 Indonesian Basic Health Research Report (Riset Kesehatan Dasar, Riskesdas) found pneumonia to be the second leading cause of death in Indonesian children under five, after diarrhea. The prevalence of pneumonia in West Sumatera was 0.7% for infants and 0.8% for children under the age of five. 2 It is difficult to distinguish between viral and bacterial pneumonia using clinical manifestations, radiological examinations, and routine laboratory tests. Bacterial cultures require a long incubation time and yield positive results in only 10-30% of patients cultured. A polymerase chain reaction (PCR) method has been used as the gold standard to diagnose bacteremia patients with good sensitivity and specificity. [3] [4] [5] [6] However, the PCR method has not been widely used due to its high cost, need for sophisticated equipment, difficult equipment maintenance, and requirement of skilled technicians. Procalcitonin has been reported to be the most accurate laboratory test to diagnose bacterial infections, with sensitivity 89%, specificity 94%, positive prediction value 94%, and negative prediction value 90%. 7 In 2000, the World Health Organization (WHO) reported that only 20 of every 100 children with respiratory infections need antibiotic therapy. 8 It is important to find a marker that can be used to immediately diagnose bacterial pneumonia, so that appropriate antibiotics can be administered. As such, treatment costs and possible side effects can be reduced, and patients' prognoses and disease severity can also be used to determine the need for ICU admission. 9, 10, 12 We aimed to assess the diagnostic validity of procalcitonin level in community-acquired bacterial pneumonia compared to PCR result as a gold standard.
Methods
This cross-sectional included children with severe pneumonia who were hospitalized in the Pediatrics Ward of Dr. M Djamil Hospital, Padang, from January to December 2013. Subjects were chosen in a nonprobability sampling with consecutive technique. The inclusion criteria were children diagnosed with severe pneumonia according to WHO criteria, who had been ill for <48 hours, had no comorbidities based on history-taking, physical examination, and previous disease history, aged 2 months to 14 years, and whose parents provided written informed consent. We excluded children with nosocomial pneumonia. This study was approved by the Ethics Committee of Dr. M. Djamil Hospital, Padang.
We recorded subjects' age, gender, and clinical findings such as cough, body temperature, respiratory rate per minute, nasal flaring/chest wall retraction, and rhonchi upon auscultation. Subjects underwent anteroposterior chest radiographs and 2 mL blood specimens were obtained from the cubital vein using aseptic and antiseptic techniques. Using the blood specimens, we examined procalcitonin levels and performed PCR analysis to assess for bacterial vs. viral etiologies in Biomedical Laboratory of Andalas University Medical School. The analysis was performed by using the 2x2 table.
Results
During the study period there were 55 children hospitalized with diagnoses of bronchopneumonia/ pneumonia, 32 of whom were included in the study. We excluded 7 children with congenital heart disease, 2 children with sepsis since hospital admission, 4 children who received previous antibiotic treatment, 4 children whose blood specimens were accidentally lysed so as to be unusable, and 6 children whose parents refused participation.
The characteristics of subjects are shown in Table 1 . The ratio of males to females was 9:7. The largest age group was 1 to 4 years (16/32) and the ratio of good nutritional status to poor nutritional status was 5:11.
Sensitivity, specificity, positive predictive value, and negative predictive value are shown in Table 2 . There were 24 patients with bacterial infections, based on both procalcitonin examination and PCR methods. However, 26 patients were considered positive for bacterial infection based on PCR methods alone, so the sensitivity of procalcitonin (using a cut-off point of 0.25 ng/L) was 92%. There were 3 pneumonia patients with non-bacterial agents of infection based on procalcitonin examination and PCR methods, while 6 patients were negative for bacterial infection incidence of pneumonia was in 1 to 5-year-old and decreased with age. Various risk factors can increase the incidence and severity of disease, as well as death due to pneumonia, including nutritional status, vitamin A and zinc supplementation, vaccinations, cigarette smoke, and air pollution. 15 We also had more pneumonia patients with poor nutritional status (22/32) than good nutritional status. Gozali also showed that nutritional status significantly affects pneumonia incidence. 16 Several studies have shown that procalcitonin can be used as diagnostic marker and to examine the severity of bacterial infection. However, procalcitonin is not useful for viral and local bacterial infections, as procalcitonin levels increase during systemic bacterial infection. 17 Lacour et al investigated about the superiority of procalcitonin in the threshold of 0.5 ng/mL compared by the peripheral blood analysis and C-reactive protein (CRP) as the specific marker of bacterial infection with sensitivity of 93%, specificity of 74%, positive predictive value of 60%, and negative predictive value of 96%. 18 Lacour et al. compared procalcitonin and C-reactive protein (CRP). They found that using a threshold value of 0.5 ng/mL, procalcitonin level had sensitivity of 93%, specificity of 74%, positive predictive value of 60%, and negative predictive value of 96% and was superior to CRP as a marker of bacterial infection. 18 We found that using a procalcitonin cut-off point of 0.25 ng/mL had the following procalcitonin diagnostic accuracy: sensitivity 92%, specificity 50%, positive predictive value 88%, and negative predictive value 60%. A meta-analysis study conducted by Simon et al. 20 reported that the sensitivity and specificity of procalcitonin was higher than those of CRP to distinguish between bacterial and viral infections (sensitivity 92% vs. 86% and specificity 73% vs. based on PCR methods alone, so the specificity of procalcitonin was 50%. Table 3 shows the results of using a procalcitonin cut-off pointof 0.5 ng/mL. The procalcitonin diagnostic accuracy obtained was sensitivity 46%, specificity 83%, positive predictive value 91%, and negative predictive value 25%. Table 4 shows that the procalcitonin cut-off pointof 0.25 ng/mL had higher sensitivity than that of 0.5 ng/mL. Hence, the lower value would be better for screening patients. However, it is important to continue vigilant patient observation for those with negative results (i.e., procalcitonin < 0.25 ng/mL) because the negative predictive value was 60%, indicating the possiblity that 40% of these patients actually have bacterial infections, despite their lower procalcitonin level.
Discussion
In our study, there were more male than female subjects (18/32 males). Similarly, Kisworini et al. and Beyeng et al. had more boys than girls in their studies, with 55% and 59.4%, respectively. 13, 14 Our largest subject age group was under five years (99%), with children aged 2-11 months comprising 46%, and those aged 1-4 years comprising 53%. This result was similar to studies by Kisworini P et al. and Beyeng et al. which had mean subject ages of 16 and 11 months, respectively. 13, 14 The peak 70%, respectively). Another study also reported that procalcitonin (cut-off point 0.25 ng/mL) had higher diagnostic accuracy than that of CRP and that total leukocytes can differ between community-acquired pneumonia and infection cause. 21 O' Connor et al.
reported that procalcitonin had sensitivity 89%, specificity 94%, positive predictive value 94%, and negative predictive value 90% in diagnosing bacterial infections. 7 Using the cut-off point of 0.5 ng/mL, procalcitonin level had a sensitivity of 46%, specificity 83%, positive predictive value 91%, and negative predictive value 25%. These values reflect the poor ability of procalcitonin as a diagnostic tool at this cut-off point to detect pneumonia caused by bacteria, but it would be more specific in ruling out pneumonia caused by non-bacterial agents.
Cahayasari et al. conducted at study in 49 children with neutropenia and fever. They reported that a procalcitonin threshold >0.84 ng/mL had sensitivity of 77.8%, specificity of 87.1%, and accuracy of 83.7% for detecting bacterial infection. 22 Also, Herawaty et al. conducted a study in children aged 3-36 months who were suspected of having bacterial infections mL was related to severity of the disease, bacteremia, and sepsis. 23 Christ-Crain et al. conducted a study in patients with lower respiratory tract infections and reported that procalcitonin levels >0.25 ng/mL indicate a bacterial cause and antibiotic therapy can be started. 11 The prospective study by Esposito et al. used -pital admission for determining antibiotic use. The antibiotic would not be administered if procalcitonin level was <0.25 ng/mL, in an effort to significantly reduce antibiotic administration and its possible side effects. 24 In conclusion, a procalcitonin cut-off point of 0.25 ng/mL can be used to screen for bacterial pneumonia as compared to a procalcitonin cut-off point of 0.5 ng/mL. However, monitoring should be continued if the result is negative, because there is a 40% chance that they do indeed have bacterial pneumonia. It is required to find another diagnostic tool with high sensitivity and specificity in identifying community bacterial pneumonia in children.
